Bioanalytical Methods - Assay List | Lambda-Novum

Bioanalytical Assays – Methods Library

• Post author:Dipesh Chodvadia
• Post published:November 15, 2025
• Post category:Blog/Labs

Lambda Therapeutic Research provides QPPV services across the EU and UK, offering companies a reliable framework to meet regulatory expectations and maintain inspection readiness at all times.

Continue ReadingBioanalytical Assays – Methods Library

Qualified Person for Pharmacovigilance (QPPV): Strengthening Compliance Across the EU and UK

Qualified Person for Pharmacovigilance (QPPV): Strengthening Compliance Across the EU and UK

• Post author:Dipesh Chodvadia
• Post published:November 12, 2025
• Post category:Blog/Pharmacovigilance/Services & Capabilities

Lambda Therapeutic Research provides QPPV services across the EU and UK, offering companies a reliable framework to meet regulatory expectations and maintain inspection readiness at all times.

Continue ReadingQualified Person for Pharmacovigilance (QPPV): Strengthening Compliance Across the EU and UK

Bioanalytical Excellence Upheld - Unannounced US FDA inspection concludes with Zero 483s - Lambda CRO

Bioanalytical Excellence Upheld – Unannounced US FDA inspection concludes with Zero 483s

• Post author:Dipesh Chodvadia
• Post published:July 19, 2025
• Post category:News

NEWS

Continue ReadingBioanalytical Excellence Upheld – Unannounced US FDA inspection concludes with Zero 483s

Lambda Clears 4 Back-to-Back US FDA PV Inspections in 12 Months Without 483s

Lambda Successfully Completes US FDA Pharmacovigilance Inspection with Zero 483s – 4th Consecutive in One Year

• Post author:Dipesh Chodvadia
• Post published:July 12, 2025
• Post category:News

NEWS

Continue ReadingLambda Successfully Completes US FDA Pharmacovigilance Inspection with Zero 483s – 4th Consecutive in One Year

US FDA Inspection Success - NO FORM 483 - Lambda CRO

Lambda Ahmedabad Successfully Completes USFDA Inspection without any 483 Observations

• Post author:Dipesh Chodvadia
• Post published:May 5, 2025
• Post category:News

NEWS

Continue ReadingLambda Ahmedabad Successfully Completes USFDA Inspection without any 483 Observations

USFDA ANDA Approval - Protein-bound Paclitaxel - Lambda Bioanalytical

USFDA Approves ANDA for Protein-Bound Paclitaxel Injection: Program supported by Lambda as the key Bioanalytical Partner

• Post author:Dipesh Chodvadia
• Post published:April 22, 2025
• Post category:News

NEWS

Continue ReadingUSFDA Approves ANDA for Protein-Bound Paclitaxel Injection: Program supported by Lambda as the key Bioanalytical Partner

EMA Excellence! - EMA Excellence Success!

Lambda Successfully Completes Multi-Site EMA Inspection for Biosimilar Product

• Post author:Dipesh Chodvadia
• Post published:March 6, 2025
• Post category:News

NEWS

Continue ReadingLambda Successfully Completes Multi-Site EMA Inspection for Biosimilar Product

Lambda Successfully Completes Swissmedic Inspection for Pharmacovigilance Services

Lambda Successfully Completes Swissmedic Inspection for Pharmacovigilance Services

• Post author:Dipesh Chodvadia
• Post published:March 1, 2025
• Post category:News

NEWS

Continue ReadingLambda Successfully Completes Swissmedic Inspection for Pharmacovigilance Services

Kazakhstan Regulatory Inspection Success - Lambda October 2024

Successful completion of the Ministry of Health inspection of the Republic of Kazakhstan (October 2024)

• Post author:Dipesh Chodvadia
• Post published:February 6, 2025
• Post category:News

NEWS

Continue ReadingSuccessful completion of the Ministry of Health inspection of the Republic of Kazakhstan (October 2024)

Ensuring Drug Safety Lambda’s Pharmacovigilance Milestones in 2024

Ensuring Drug Safety: Lambda’s Pharmacovigilance Milestones in 2024

• Post author:Dipesh Chodvadia
• Post published:January 31, 2025
• Post category:Blog/Pharmacovigilance

BLOG

Continue ReadingEnsuring Drug Safety: Lambda’s Pharmacovigilance Milestones in 2024